Related Experiment Video
Updated: Aug 17, 2026

Murine Isolated Heart Model of Myocardial Stunning Associated with Cardioplegic Arrest
Published on: August 6, 2015
Superior protective effect of low-calcium, magnesium-free potassium cardioplegic solution on ischemic myocardium.
K Kinoshita1, M Oe, K Tokunaga
1Division of Cardiovascular Surgery, Kyushu University, Faculty of Medicine, Fukuoka, Japan.
Insights
Low-calcium, magnesium-free potassium cardioplegic solution significantly improved heart recovery after surgery compared to St. Thomas
Area of Science:
- Cardiology
- Cardiac Surgery
- Cardiothoracic Surgery
Background:
- Myocardial ischemia during cardiac surgery poses a significant risk to cardiac function.
- Potassium cardioplegic solutions are crucial for myocardial protection during cardiac operations.
- The composition of cardioplegic solutions, particularly calcium and magnesium levels, may influence myocardial recovery.
Purpose of the Study:
- To evaluate the protective effect of a low-calcium, magnesium-free potassium cardioplegic solution on ischemic myocardium in adult patients undergoing heart operations.
- To compare the postreperfusion recovery of cardiac function and electrical activity between patients receiving a modified cardioplegic solution and a standard solution.
Main Methods:
- A prospective study involving 34 adult patients undergoing heart operations.
- Patients were divided into two groups: Group I (16 patients) received low-calcium, magnesium-free potassium cardioplegic solution, and Group II (18 patients) received St. Thomas' Hospital solution (calcium and magnesium-enriched).
- Cardiac function and electrical activity were assessed during the reperfusion period, along with serum creatine kinase MB activity and the need for inotropic support.
Main Results:
- Fewer patients in Group I required electrical defibrillation (25.5% vs. 83.3%, p < 0.005) and experienced bradyarrhythmias (6.3% vs. 44.4%, p < 0.05) compared to Group II.
- Serum creatine kinase MB activity was significantly lower in Group I (12.3 IU/L vs. 42.6 IU/L, p < 0.05) at 15 minutes of reperfusion.
- Postischemic left ventricular function recovery was significantly better in Group I (160.4% vs. 47.8%, p < 0.05) for patients undergoing aortic valve replacement.
Conclusions:
- Low-calcium, magnesium-free potassium cardioplegic solution provides superior protection to the ischemic myocardium during cardiac surgery.
- This modified cardioplegic solution promotes better functional and electrical recovery of the heart during the early reperfusion period.
- The findings suggest that extracellular calcium and magnesium levels play a critical role in myocardial protection and recovery post-ischemia.
Abstract:
The protective effect of low-calcium, magnesium-free potassium cardioplegic solution on ischemic myocardium has been assessed in adult patients undergoing heart operations. Postreperfusion recovery of cardiac function and electrical activity was evaluated in 34 patients; 16 received low-calcium, magnesium-free potassium cardioplegic solution (group I) and 18 received St. Thomas' Hospital solution, which is enriched with calcium and magnesium (group II). There were no significant differences between the two groups in age, sex, body weight, and New York Heart Association functional class. Aortic occlusion time (107.3 +/- 46.8 minutes versus 113.6 +/- 44.3 minutes), highest myocardial temperature during elective global ischemia (11.5 degrees C +/- 3.1 degrees C versus 9.3 degrees C +/- 3.2 degrees C), and total volume of cardioplegic solution (44.2 +/- 20.5 ml/kg versus 43.4 +/- 17.6 ml/kg) were also similar in the two groups. On reperfusion, electrical defibrillation was required in four cases (25.5%) in group I and in 15 cases (83.3%) in group II (p less than 0.005), and bradyarrhythmias were significantly more prevalent in group II (6.3% versus 44.4%; p less than 0.05). Serum creatine kinase MB activity at 15 minutes of reperfusion (12.3 +/- 17.0 IU/L versus 42.6 +/- 46.1 IU/L; p less than 0.05) and the dose of dopamine or dobutamine required during the early phase of reperfusion (1.8 +/- 2.5 micrograms/kg/min versus 6.1 +/- 3.3 micrograms/kg/min; p less than 0.0002) were both significantly greater in group II. Postischemic left ventricular function, as assessed by percent recovery of the left ventricular end-systolic pressure-volume relationship in patients who underwent aortic valve replacement alone, was significantly better in group I (160.4% +/- 45.5% versus 47.8% +/- 12.9%; p less than 0.05). Serum level of calcium and magnesium ions was significantly lower in group I. Thus low-calcium, magnesium-free potassium cardioplegic solution provided excellent protection of the ischemic heart, whereas St. Thomas' Hospital solution with calcium and magnesium enabled relatively poor functional and electrical recovery of the heart during the early reperfusion period. These results might be related to differing levels of extracellular calcium and magnesium on reperfusion.
Related Concept Videos
Heart Failure Drugs: Inotropic Agents
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Imaging Studies for Cardiovascular System V: CT
Cardiopulmonary Resuscitation IV: Pharmacological Management

